FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W268331318> ?p ?o ?g. }

• W268331318 endingPage "10" @default.
• W268331318 startingPage "1" @default.
• W268331318 abstract "Elevated blood lead levels (BLLs) in adults can damage the cardiovascular, central nervous, reproductive, hematologic, and renal systems. The majority of cases are workplace-related. U.S. Department of Health and Human Services recommends that BLLs among all adults be reduced to < 25 microg/dL. The highest BLL acceptable by standards of the U.S. Occupational Safety and Health Administration is 40 microg/dL. The mean BLL of adults in the United States is < 3 microg/dL.This report covers cases of adults (aged > or = 16 years) with BLLs > or = 25 microg/dL, as reported by 25 states during 1998-2001.Since 1987, CDC has sponsored the state-based Adult Blood Lead Epidemiology and Surveillance (ABLES) program to track cases of elevated BLLs and provide intervention consultation and other assistance. Overall ABLES program data were last published in 1999 for the years 1994-1997. This report provides an update with data from 25 states reporting for > or = 2 years during 1998-2001. During that period, the ABLES program funded surveillance in 21 states - Alabama, Arizona, Connecticut, Iowa, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Washington, Wisconsin, and Wyoming. Four additional states - California, Nebraska, New Hampshire, and Utah contributed data without CDC funding.During 1998-2001, the overall program's annual mean state prevalence rate for adults with BLLs > or = 25 microg/dL was 13.4/100,000 employed adults. This compares with 15.2/100,000 for 1994-1997. Yearly rates were 13.8 (1998), 12.9 (1999), 14.3 (2000), and 12.5 (2001). For adults with BLLs > or = 40 microg/dL, the overall program's annual mean state prevalence rare during 1998-2001 was 2.9/ 100,000 employed adults. This compares with 3.9/100,000 for 1994-1997. Yearly rates were 3.3 (1998), 2.5 (1999), 2.9 (2000), and 2.8 (2001).Although certain limitations exist, the overall ABLES data indicate a declining trend in elevated BLLs among employed adults.ABLES-funded states increased from 21 to 35 in 2002, and more detailed reporting requirements were put into effect. These, and other improvements, will enable the ABLES program to work more effectively toward its 2010 target of eliminating all cases of BLLs > or = 25 microg/dL in adults caused by workplace exposures." @default.
• W268331318 created "2016-06-24" @default.
• W268331318 creator A5000986603 @default.
• W268331318 creator A5006388307 @default.
• W268331318 creator A5006960500 @default.
• W268331318 creator A5007848772 @default.
• W268331318 creator A5010350536 @default.
• W268331318 creator A5015762075 @default.
• W268331318 creator A5022182524 @default.
• W268331318 creator A5023143379 @default.
• W268331318 creator A5024194256 @default.
• W268331318 creator A5028266489 @default.
• W268331318 creator A5028853975 @default.
• W268331318 creator A5030311164 @default.
• W268331318 creator A5041454018 @default.
• W268331318 creator A5052029446 @default.
• W268331318 creator A5052390327 @default.
• W268331318 creator A5053951924 @default.
• W268331318 creator A5057018479 @default.
• W268331318 creator A5058333103 @default.
• W268331318 creator A5060240086 @default.
• W268331318 creator A5062163493 @default.
• W268331318 creator A5066247604 @default.
• W268331318 creator A5070663604 @default.
• W268331318 creator A5071893612 @default.
• W268331318 creator A5074872256 @default.
• W268331318 creator A5079081431 @default.
• W268331318 creator A5089131167 @default.
• W268331318 date "2002-12-13" @default.
• W268331318 modified "2023-09-27" @default.
• W268331318 title "Adult blood lead epidemiology and surveillance--United States, 1998-2001." @default.
• W268331318 cites W1715326565 @default.
• W268331318 cites W17290579 @default.
• W268331318 cites W2014293850 @default.
• W268331318 cites W2040774704 @default.
• W268331318 cites W2043170001 @default.
• W268331318 cites W2058133603 @default.
• W268331318 cites W2072275434 @default.
• W268331318 cites W2116560673 @default.
• W268331318 cites W2147006714 @default.
• W268331318 cites W2167225290 @default.
• W268331318 cites W2253939631 @default.
• W268331318 cites W2325475066 @default.
• W268331318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12528812" @default.
• W268331318 hasPublicationYear "2002" @default.
• W268331318 type Work @default.
• W268331318 sameAs 268331318 @default.
• W268331318 citedByCount "7" @default.
• W268331318 countsByYear W2683313182015 @default.
• W268331318 countsByYear W2683313182021 @default.
• W268331318 crossrefType "journal-article" @default.
• W268331318 hasAuthorship W268331318A5000986603 @default.
• W268331318 hasAuthorship W268331318A5006388307 @default.
• W268331318 hasAuthorship W268331318A5006960500 @default.
• W268331318 hasAuthorship W268331318A5007848772 @default.
• W268331318 hasAuthorship W268331318A5010350536 @default.
• W268331318 hasAuthorship W268331318A5015762075 @default.
• W268331318 hasAuthorship W268331318A5022182524 @default.
• W268331318 hasAuthorship W268331318A5023143379 @default.
• W268331318 hasAuthorship W268331318A5024194256 @default.
• W268331318 hasAuthorship W268331318A5028266489 @default.
• W268331318 hasAuthorship W268331318A5028853975 @default.
• W268331318 hasAuthorship W268331318A5030311164 @default.
• W268331318 hasAuthorship W268331318A5041454018 @default.
• W268331318 hasAuthorship W268331318A5052029446 @default.
• W268331318 hasAuthorship W268331318A5052390327 @default.
• W268331318 hasAuthorship W268331318A5053951924 @default.
• W268331318 hasAuthorship W268331318A5057018479 @default.
• W268331318 hasAuthorship W268331318A5058333103 @default.
• W268331318 hasAuthorship W268331318A5060240086 @default.
• W268331318 hasAuthorship W268331318A5062163493 @default.
• W268331318 hasAuthorship W268331318A5066247604 @default.
• W268331318 hasAuthorship W268331318A5070663604 @default.
• W268331318 hasAuthorship W268331318A5071893612 @default.
• W268331318 hasAuthorship W268331318A5074872256 @default.
• W268331318 hasAuthorship W268331318A5079081431 @default.
• W268331318 hasAuthorship W268331318A5089131167 @default.
• W268331318 hasConcept C107130276 @default.
• W268331318 hasConcept C118552586 @default.
• W268331318 hasConcept C138816342 @default.
• W268331318 hasConcept C142724271 @default.
• W268331318 hasConcept C144024400 @default.
• W268331318 hasConcept C149923435 @default.
• W268331318 hasConcept C2777126965 @default.
• W268331318 hasConcept C2781037878 @default.
• W268331318 hasConcept C2908647359 @default.
• W268331318 hasConcept C71924100 @default.
• W268331318 hasConcept C74909509 @default.
• W268331318 hasConcept C99454951 @default.
• W268331318 hasConceptScore W268331318C107130276 @default.
• W268331318 hasConceptScore W268331318C118552586 @default.
• W268331318 hasConceptScore W268331318C138816342 @default.
• W268331318 hasConceptScore W268331318C142724271 @default.
• W268331318 hasConceptScore W268331318C144024400 @default.
• W268331318 hasConceptScore W268331318C149923435 @default.
• W268331318 hasConceptScore W268331318C2777126965 @default.
• W268331318 hasConceptScore W268331318C2781037878 @default.
• W268331318 hasConceptScore W268331318C2908647359 @default.

• next